These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9117144)
21. [New information on the pathophysiology of atherosclerosis]. Reiner Z; Tedeschi-Reiner E Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms modifying atherosclerotic disease - from lipids to vascular biology. Weissberg P Atherosclerosis; 1999 Sep; 147 Suppl 1():S3-10. PubMed ID: 10575056 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Hunninghake DB Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501 [TBL] [Abstract][Full Text] [Related]
25. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Vita JA; Yeung AC; Winniford M; Hodgson JM; Treasure CB; Klein JL; Werns S; Kern M; Plotkin D; Shih WJ; Mitchel Y; Ganz P Circulation; 2000 Aug; 102(8):846-51. PubMed ID: 10952951 [TBL] [Abstract][Full Text] [Related]
26. Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization. Bates ER Am J Cardiol; 2000 Dec; 86(12A):28L-34L. PubMed ID: 11374853 [TBL] [Abstract][Full Text] [Related]
27. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Hamasaki S; Higano ST; Suwaidi JA; Nishimura RA; Miyauchi K; Holmes DR; Lerman A Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):737-43. PubMed ID: 10712399 [TBL] [Abstract][Full Text] [Related]
28. [The effect of reduced cholesterol on coronary arteries]. Landmark K; Reikvam A Tidsskr Nor Laegeforen; 1998 Oct; 118(24):3805-9. PubMed ID: 9816952 [TBL] [Abstract][Full Text] [Related]
29. Improvement in endothelial dysfunction with LDL cholesterol level < 80 mg/dl in type 2 diabetic patients. Sheu WH; Chen YT; Lee WJ Diabetes Care; 2001 Aug; 24(8):1499-501. PubMed ID: 11473096 [No Abstract] [Full Text] [Related]
30. Cholesterol lowering and endothelial function. Vogel RA Am J Med; 1999 Nov; 107(5):479-87. PubMed ID: 10569303 [TBL] [Abstract][Full Text] [Related]
31. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532 [TBL] [Abstract][Full Text] [Related]
32. Prevention of plaque rupture: a new paradigm of therapy. Forrester JS Ann Intern Med; 2002 Nov; 137(10):823-33. PubMed ID: 12435220 [TBL] [Abstract][Full Text] [Related]
33. Toward the quiescent coronary plaque. MacIsaac AI; Thomas JD; Topol EJ J Am Coll Cardiol; 1993 Oct; 22(4):1228-41. PubMed ID: 8104965 [TBL] [Abstract][Full Text] [Related]
34. Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials. White CW Am J Med; 1998 Jul; 105(1A):63S-68S. PubMed ID: 9707270 [TBL] [Abstract][Full Text] [Related]
35. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. van Haelst PL; van Doormaal JJ; Asselbergs FW; van Roon AM; Veeger NJ; Henneman MM; Smit AJ; Tervaert JW; May JF; Gans RO Clin Sci (Lond); 2003 Jun; 104(6):627-32. PubMed ID: 12558496 [TBL] [Abstract][Full Text] [Related]
36. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630 [TBL] [Abstract][Full Text] [Related]
37. Lipid lowering therapy and stabilization of atherosclerotic plaques. Krone W; Müller-Wieland D Thromb Haemost; 1999 Sep; 82 Suppl 1():60-1. PubMed ID: 10695487 [TBL] [Abstract][Full Text] [Related]
38. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Schartl M; Bocksch W; Koschyk DH; Voelker W; Karsch KR; Kreuzer J; Hausmann D; Beckmann S; Gross M Circulation; 2001 Jul; 104(4):387-92. PubMed ID: 11468198 [TBL] [Abstract][Full Text] [Related]
39. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial. Takase S; Matoba T; Nakashiro S; Mukai Y; Inoue S; Oi K; Higo T; Katsuki S; Takemoto M; Suematsu N; Eshima K; Miyata K; Yamamoto M; Usui M; Sadamatsu K; Satoh S; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Egashira K; Sunagawa K Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):350-358. PubMed ID: 27932353 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors]. Tschudi MR; Noll G; Lüscher TP Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]